MedPath

Saffron and decrease of sexual dysfunction induced by fluoxeti

Phase 2
Conditions
Sexual dysfunction.
Lack or loss of sexual desire
Registration Number
IRCT138711121556N3
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
40
Inclusion Criteria

Inclusion Criteria: at least 4 weeks usage of fluoxetin before study, do not use any psychotherapeutics except Selective Seretonin Reuptake Inhibitors, lack of chronic and organic disorders including cardiovascular diseases, informed consent.

Exclusion Criteria

substance dependence, organic disorders, other psychiatric comorbidity including biploar disorder, use of psychotropic drugs.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Score of international index of Erectile Function. Timepoint: every two weeks. Method of measurement: use of international index of Erectile Function.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath